AMG:ETR
Amgen
413,55 €
arrow_downward
-0,07%(-0,30) 1K
9-noy, 17:35:42 (GMT+1) · EUR
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoAMG tikeri uchun statistika yaratilmoqda...
Ochish
414,00 €
Yuqori
416,75 €
Past
408,20 €
Bozor kapitali
251,65Â mlrd
Oʻrtacha hajm
548,00
Hajmi
881,00
52 haftalik eng yuqori
438,75 €
52 haftalik eng past
267,60 €
Xodimlar soni
32Â ming
Ochish
414,00 €
Yuqori
416,75 €
Past
408,20 €
Bozor kapitali
251,65Â mlrd
Oʻrtacha hajm
548,00
Hajmi
881,00
52 haftalik eng yuqori
438,75 €
52 haftalik eng past
267,60 €
Xodimlar soni
32Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Investing.com Canada
·
29 daqiqa oldin
Form 4 Amgen Inc: Omar Ishrak (Director) For: 6 November By Investing.com
MarketWatch
·
4 soat oldin
Amgen Inc. stock rises Monday, still underperforms market
Yahoo Finance UK
·
12 soat oldin
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Amgen
·
5 kun oldin
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
Profil
Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. The company is ranked 18th on the list of largest biomedical companies by revenue. The name "AMGen" is a portmanteau of the company's original name, Applied Molecular Genetics.
The company's major products are Prolia and XGEVA to treat osteoporosis and bone diseases, Repatha to treat hyperlipidemia, Otezla to treat psoriasis and psoriatic arthritis, Enbrel to treat autoimmune diseases, Evenity to treat osteoporosis, Tepezza to treat Graves' ophthalmopathy, Blincyto to treat acute lymphoblastic leukemia, Nplate to regulate platelet production, Tezspire to treat asthma, Kyprolis to treat cancer, Aranesp to stimulate erythropoiesis, Krystexxa to treat gout, and Vectibix, a monoclonal antibody.
Amgen has 17 clinical programs underway in Phase III, eight in Phase II, and 19 in Phase I. Its pipeline includes MariTide, an anti-obesity medication administered once per month by injection.
The company receives approximately 80% of its revenues from sales to the three large U.S. drug wholesalers: McKesson Corporation, Cencora, and Cardinal Health. Wikipedia
Amgen haqida
CEORobert A. Bradway
Xodimlar soni31,5Â ming
Asos solingan1980
Bosh ofislarTauzand-Oks, Kaliforniya, Amerika Qo‘shma Shtatlari
SektorHealth Care
Soha-
Veb-saytamgen.com